Imfinzi (durvalumab) - AstraZeneca
Aidixi (disitamab vedotin) - Pfizer, RemeGen
Imjudo (tremelimumab-actl) - AstraZeneca
Padcev (enfortumab vedotin-ejfv) - Astellas, Pfizer
Tecentriq (atezolizumab) - Roche
Provenge (sipuleucel-T) - Bausch Health
Keytruda (pembrolizumab) - Merck (MSD)
Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Bioscience, Coherus Oncology
http://www.ncbi.nlm.nih.gov/pubmed/42656261
 
Nabil Ismaili; Sanaa El Majjaoui
 
Aug 28, 2026
 
Prev Next